Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opsens Inc T.OPS

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.


TSX:OPS - Post by User

Comment by Possibleidiot01on Feb 19, 2023 6:38pm
145 Views
Post# 35294544

RE:RE:Waiting for SWAV to take us over

RE:RE:Waiting for SWAV to take us overI am focused on two words in the Shockwave Medical description - "minimally invasive"
There is no doubt Shockwave needs to measure blood flow ; I just wonder if the minimally invasive market is bigger than the
surgery market .

In 2021, the global cardiac surgery market size is projected to reach over $14.2 billion, with the market for cerebral embolic protection devices showing the fastest growth in value. In spite of COVID19, the global market size is expected to increase over the forecast period and exceed $20.4 billion by 2027. Currently, the majority of the global market share is controlled by three main companies – Edwards Lifesciences, Medtronic, and Abbott.

<< Previous
Bullboard Posts
Next >>